Back to Search
ERIC HOLLANDER, M.D.
M.D.
Psychiatry Physician
NPI: 1336288638Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
155389(NY)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
2
With Results
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
NCT01337700COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Divalproex Sodium ER in Adult Autism
NCT00211796COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
NCT00211744COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Fluoxetine in Pediatric Body Dysmorphic Disorder
NCT00245635COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
PMID 20816027·J Clin Psychiatry·2011
2-rct
Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders.
PMID 18412058·Depress Anxiety·2008
8-other
FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism.
PMID 18781089·Neuropsychobiology·2008
2-rct
Oxytocin increases retention of social cognition in autism.
PMID 16904652·Biol Psychiatry·2007
3-trial
Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.
PMID 16316486·Int J Neuropsychopharmacol·2006
3-trial
Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
PMID 16528143·Int Clin Psychopharmacol·2006
5-case
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.
PMID 17069543·J Child Adolesc Psychopharmacol·2006
2-rct
Striatal volume on magnetic resonance imaging and repetitive behaviors in autism.
PMID 15939406·Biol Psychiatry·2005
4-observational
Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
PMID 15741486·Am J Psychiatry·2005
3-trial
Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
PMID 15625212·Am J Psychiatry·2005
3-trial
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism.
PMID 15602505·Neuropsychopharmacology·2005
3-trial
Beyond refractory obsessions and anxiety states: toward remission.
PMID 15554781·J Clin Psychiatry·2004
8-other
Impact of recent findings on study design of future autism clinical trials.
PMID 14999175·CNS Spectr·2004
6-review
Targeted treatments for symptom domains in child and adolescent autism.
PMID 12957098·Lancet·2003
4-observational
Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
PMID 14604454·Int J Neuropsychopharmacol·2003
3-trial
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
PMID 12823077·J Clin Psychiatry·2003
3-trial
Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
PMID 14628989·J Clin Psychiatry·2003
3-trial
Venlafaxine in treatment-resistant obsessive-compulsive disorder.
PMID 12755657·J Clin Psychiatry·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 901 FIFTH AVE
NEW YORK, NY 10021 - Phone
- (212) 873-4051
Quick Facts
- NPI
- 1336288638
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile